Skip to NavigationSkip to content

News

Shares in the London listed addiction specialist Indivior surged in price today, as the Indian pharmaceutical company Dr Reddy’s Laboratories was...
British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’...
A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women who claimed that the...
A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer Scott Raymond Dozier,...
After making headlines with its mammoth deal to acquire Shire earlier this year, Takeda has emerged with new Phase 3 data for its oral proteasome...
In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the US president whose clashes with the Pfizer...
Otsuka Pharmaceutical has announced it has reached a definitive, board-approved agreement with Visterra to acquire the latter company in an all-...
AbbVie and Janssen have announced that Imbruvica (ibrutinib) failed to achieve the primary endpoint in a late-stage study assessing its use in...
Pfizer has announced plans to reorganise into three separate units through the separation of its consumer health care business from the other two...
Novartis has announced that it is to terminate its research operations into antibiotics and antivirals in a reorganisation effort that will see 140...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches